Irish lawyer, Niall Neligan will give an overview of the current situation concerning the regulation of cannabis for medical and novel food use in Ireland. Whilst cannabis remains prohibited for adult use, like many jurisdictions there's a vibrant cannabis community and a strong presence from North American cannabis companies who view Ireland as a launchpad into the larger European market.
Niall will discuss cannabis jurisdiction, legislation, regulation, Medical Cannabis Access Programme (MCAP, the Specified Controlled Drugs (Cannabis-Based Medical Products), indications, CBD - Novel Foods (Conflict of Laws), and adult use in the Republic of Ireland.
This program is eligible for 1 hours of General CLE credit in 60-minute states, and 1.2 hours of General CLE credit in 50-minute states. Credit hours are estimated and are subject to each state’s approval and credit rounding rules.
INCBA webinars are eligible for credit in the following states: AR, AL, AK, AZ, CA, CO, CT,DE, GA, HI, IL, IN, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OR, PA, TN, TX, UT, VT, WV, and WI . Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted. For many live events, credit approval is not received prior to the program.
INCBA on demand programs are eligible for credit in the following states: AR, AL, AK, AZ, CA, CO, CT,DE, GA, HI, IL, IN, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OR, PA, TN, TX, UT, VT, WV, and WI . Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted.
For current accreditation status, please select your jurisdiction below.
|MISUSE OF DRUGS (DESIGNATION) (AMENDMENT) ORDER 2019 (97 KB)||5 Pages||Available after Purchase|
|Court of Justice of the European Union PRESS RELEASE No 141/20 (236.6 KB)||2 Pages||Available after Purchase|
|MISUSE OF DRUGS (PRESCRIPTION AND CONTROL OF SUPPLY OF CANNABIS FOR MEDICAL USE) (AMENDMENT) REGULATIONS 2020 (138.9 KB)||5 Pages||Available after Purchase|
|MISUSE OF DRUGS (AMENDMENT) REGULATIONS 2019 (100 KB)||5 Pages||Available after Purchase|
|MISUSE OF DRUGS ACT 1977 REVISED Updated to 29 October 2020 (1.4 MB)||80 Pages||Available after Purchase|
"Lawyer, Author and Lecturer in Drug Policy Regulation and Law Reform at Technological University Dublin. In 2016, founded Fweed, a Public Advocacy & Drug Policy Law Reform consultancy whose mission is to persuade the Irish Government to regulate cannabis for medical and adult use.
In 2017, co-authored the Controlled Drug and & Harm Reduction Bill put before the Irish Parliament to decriminalise controlled drugs for adult use. In July 2018, published a ""21st Century Guide to Regulating Cannabis for Adult use. The guide was launched at a public lecture hosted by the Irish Parliament.
In November 2018, published an article in the peer reviewed Medico-Legal Journal entitled ""Medical Cannabis and the Law in Ireland, a critical evaluation of Doctor-Patient Access to Medical Cannabis under the existing Licensing Rules and the Government's Proposed Enhanced Access Scheme.""
Between 2018-2020, served as Business Development, Legal Affairs and Regulatory Consultant for Tilray Europe, answering directly to the CEO of Tilray, the Managing Director of Tilray Europe and the Head of European Business Development advising on medical cannabis and novel food regulation.
In July 2019, alongside the Head of European Business Development spearheaded the team which negotiated and received the first ministerial license from the Irish Government to import and distribute a Cannabis-Based Medicinal Product (Tilray 10:10 THC CBD Oral Solution) into Ireland. In January 2020, achieved authorisation for Tilray's 10:10 Oral Solution as a ""Specified Controlled Drug"" for patient use under Ireland's Medical Cannabis Access Programme."
Please wait ...